The sellers of Supple, a glucosamine and chondroitin liquid supplement, have agreed to settle Federal Trade Commission charges that they falsely advertised that their product provided complete relief from chronic and severe joint pain caused by arthritis and fibromyalgia and was scientifically proven to eliminate joint pain

See the full post at FTC.gov